Clyde Biosciences is a specialized CRO focused on measuring and interpreting drug effects on cardiac cell function. Our unique approach allows in a single assay to screen for a broad spectrum of cardiovascular liabilities that include single and multiple ion channel effects, inotropic actions, time dependent effects, complex pharmacology, chronic effects and cardiotoxicity. This allows for early screening of candidate compounds as well as supporting late stage compounds with known cardiac liabilities needing risk assessment. We support drug development across a broad array of areas including heart failure, vascular biology, neural, oncology, diabetes and metabolism, immunology and infectious diseases.